HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Deodhar, A A Articles by Woolf, A D Search for Related Content PubMed PubMed Citation Articles by Deodhar, A A Articles by Woolf, A D

Hand bone densitometry in rheumatoid arthritis, a five year longitudinal study: an outcome measure and a prognostic marker

¹ Oregon Health Sciences University, Portland, OR, USA
² Royal Cornwall Hospital, Truro, UK
³ Kings College Hospital, London, UK

Correspondence to:
Correspondence to:
Dr A A Deodhar, Division of Arthritis and Rheumatic Diseases (OPO9), Oregon Health Sciences University, Portland, OR 97201, USA;
deodhara{at}ohsu.edu

ABSTRACT
Objective: To investigate whether hand bone mineral content (BMC) measurement is an outcome measure for RA and whether the early changes in hand BMC predict functional disability.

Methods: Tender and swollen joints in hands and body, HAQ score, Larsen score on hand radiographs, serum CRP, and hand BMC measurement by DXA were studied every six months for five years in 40 patients with early RA. At the final visit, patients completed the SF-36 and Duruoz hand function questionnaires.

Results: All patients completed two years and 29 completed five years’ follow up. Hand BMC worsened over the first three years (percentage loss from baseline: mean (SD) -5.5 (7.2), -7.5 (8.4), -9.8 (9.4)) and stabilised over last two years (–9.9 (8.8), -10 (7.8)). Baseline disease activity and function correlated with hand BMC loss at five years (swollen joints in hands: r=-0.38, p=0.043; swollen joints in body: r=-0.47, p=0.01; HAQ: r=-0.52, p=0.004). Percentage change in hand BMC over five years correlated with SF-36 physical function (r=0.61, p<0.01), hand function (r=-0.64, p<0.01), HAQ score (r=-0.63, p<0.01) at five years. Relative risk of bad hand functional outcome at five years was significantly higher for patients with hand BMC loss of 1.17 g (smallest detectable difference) than for patients with less bone loss within the first six months (OR=6.9, 95% CI 1.3 to 34.5, p<0.02).

Conclusion: Early loss of hand BMC in patients with RA is a composite marker of disease activity and functional status and can predict poor functional outcome.

Keywords: hand bone mineral content; bone densitometry; rheumatoid arthritis; outcome

Abbreviations: BMC, bone mineral content; DHI, Duruoz hand index; DMARDs, disease modifying antirheumatic drugs; DXA, dual energy x ray absorptiometry; HAQ, Health Assessment Questionnaire; RA, rheumatoid arthritis; SF-36, Short Form-36

This article has been cited by other articles:

				G. Haugeberg, M. J Green, P. G Conaghan, M. Quinn, R. Wakefield, S. M Proudman, S. Stewart, E. Hensor, and P. Emery Hand bone densitometry: a more sensitive standard for the assessment of early bone damage in rheumatoid arthritis Ann Rheum Dis, November 1, 2007; 66(11): 1513 - 1517. [Abstract] [Full Text] [PDF]

				G Haugeberg, M J Green, M A Quinn, H Marzo-Ortega, S Proudman, Z Karim, R J Wakefield, P G Conaghan, S Stewart, and P Emery Hand bone loss in early undifferentiated arthritis: evaluating bone mineral density loss before the development of rheumatoid arthritis Ann Rheum Dis, June 1, 2006; 65(6): 736 - 740. [Abstract] [Full Text] [PDF]

				G. Haugeberg, A. Strand, T. K. Kvien, and J. R. Kirwan Reduced Loss of Hand Bone Density With Prednisolone in Early Rheumatoid Arthritis: Results From a Randomized Placebo-Controlled Trial Arch Intern Med, June 13, 2005; 165(11): 1293 - 1297. [Abstract] [Full Text] [PDF]